Landry et al proposed a new TNM staging system for patients with an appendiceal carcinoid tumor. The authors are from the University of Louisville.
Parameters:
(1) diameter of the tumor in centimeters
(2) regional lymph node metastases
(3) distant metastases
|
Parameter |
Finding |
TNM Designation |
|
diameter of the tumor |
< 2.0 cm |
T1 |
|
|
2.0 - 2.99 cm |
T2 |
|
|
>= 3.0 cm |
T3 |
|
regional lymph node metastases |
none |
N0 |
|
|
>= 1 |
N1 |
|
distant metastases |
none |
M0 |
|
|
present |
M1 |
|
TNM |
Stage |
|
T1 N0 M0 |
I |
|
T2 N0 M0 |
II |
|
T3 N0 M0 |
III |
|
T1 N1 M0 |
II |
|
T2 N1 M0 |
III |
|
T3 N1 M0 |
III |
|
any M1 |
IV |
|
Stage |
10 Year Survival |
|
I |
100% |
|
II |
100% |
|
III |
63% |
|
IV |
17% |
Specialty: Hematology Oncology, Surgery, general, Endocrinology
ICD-10: ,
